Signal Labs aggregates de-identified genomic and clinical data from rare disease patient networks, accelerating discovery of novel biomarkers and therapeutic targets. Headquartered in Adelaide and integrated with SA Health, it provides open-access datasets to NHMRC-funded researchers. Already sequenced 800+ rare disease patients.